Literature DB >> 12517877

Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae.

Emma Meats1, Angela B Brueggemann, Mark C Enright, Karen Sleeman, David T Griffiths, Derrick W Crook, Brian G Spratt.   

Abstract

Serotype changes among natural isolates of Streptococcus pneumoniae are well documented and occur by recombinational exchanges at the capsular biosynthetic locus. However, the frequency with which this phenomenon occurs within the nasopharynx of children is not clear and is likely to be highest in the nasopharynx of children, who have high rates of pneumococcal carriage. A birth cohort of 100 infants was studied, and pneumococci were recovered from nasopharyngeal samples taken at monthly intervals during the first 6 months of life and then at 2-monthly intervals until the age of 2 years. Among the 1,353 nasopharyngeal samples were 523 that contained presumptive pneumococci, and three colonies from each were serotyped. A total of 333 isolates, including all isolates of differing serotypes from the same child, were characterized by multilocus sequence typing. Sixty-eight children carried multiple serotypes during the first 2 years of life. Two children carried a typeable and a nonserotypeable pneumococcus of identical genotype, and five children carried genetically indistinguishable isolates of serotypes 15B and 15C. These isolates were considered, respectively, to be due to loss of capsule expression and the known ability of serotype 15B and 15C pneumococci to interconvert by loss or gain of an acetyl group on the capsular polysaccharide. In all other cases, isolates from the same children that differed in serotype also differed in genotype, indicating the acquisition of a different pneumococcal strain rather than a change in capsular type. There was therefore no evidence in this study for any change of serotype due to recombinational replacements at the capsular locus among the pneumococci carried within the nasopharynges of the children.

Entities:  

Mesh:

Year:  2003        PMID: 12517877      PMCID: PMC149619          DOI: 10.1128/JCM.41.1.386-392.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Prevention of pneumococcal disease by vaccination: does serotype replacement matter?

Authors:  B G Spratt; B M Greenwood
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

2.  Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

Authors:  Ron Dagan; Noga Givon-Lavi; Orly Zamir; Merav Sikuler-Cohen; Lior Guy; Jacob Janco; Pablo Yagupsky; Drora Fraser
Journal:  J Infect Dis       Date:  2002-03-04       Impact factor: 5.226

3.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Authors:  S B Black; H R Shinefield; J Hansen; L Elvin; D Laufer; F Malinoski
Journal:  Pediatr Infect Dis J       Date:  2001-12       Impact factor: 2.129

Review 6.  The pneumococcus: carriage, disease and conjugate vaccines.

Authors:  Steven Obaro; Richard Adegbola
Journal:  J Med Microbiol       Date:  2002-02       Impact factor: 2.472

7.  Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a region.

Authors:  Tracey J Coffey; Margaret Daniels; Mark C Enright; Brian G Spratt
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

8.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

Review 9.  Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance.

Authors:  K P Klugman
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

10.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

View more
  28 in total

1.  Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete.

Authors:  William P Hanage; Jonathan A Finkelstein; Susan S Huang; Stephen I Pelton; Abbie E Stevenson; Ken Kleinman; Virginia L Hinrichsen; Christophe Fraser
Journal:  Epidemics       Date:  2010-06       Impact factor: 4.396

2.  Neutral microepidemic evolution of bacterial pathogens.

Authors:  Christophe Fraser; William P Hanage; Brian G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

3.  A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus.

Authors:  W P Hanage; T Kaijalainen; A Saukkoriipi; J L Rickcord; B G Spratt
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.

Authors:  Marc Lipsitch; Osman Abdullahi; Alexander DʼAmour; Wen Xie; Daniel M Weinberger; Eric Tchetgen Tchetgen; J Anthony G Scott
Journal:  Epidemiology       Date:  2012-07       Impact factor: 4.822

5.  Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus isolated from the nasopharynx of healthy children attending day-care centres in the Czech Republic.

Authors:  H Zemlicková; P Urbásková; V Adámková; J Motlová; V Lebedová; B Procházka
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

6.  Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy.

Authors:  S M McChlery; K J Scott; S C Clarke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

7.  Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines.

Authors:  William P Hanage; Kari Auranen; Ritva Syrjänen; Elja Herva; P Helena Mäkelä; Terhi Kilpi; Brian G Spratt
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae.

Authors:  Kedibone Ndlangisa; Mignon du Plessis; Mushal Allam; Nicole Wolter; Linda de Gouveia; Keith P Klugman; Cheryl Cohen; Rebecca A Gladstone; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

9.  High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study.

Authors:  Raquel Sá-Leão; Sónia Nunes; António Brito-Avô; Carla R Alves; João A Carriço; Joana Saldanha; Jonas S Almeida; Ilda Santos-Sanches; Hermíniade de Lencastre
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

10.  Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

Authors:  Elizabeth A Clutterbuck; Sarah Oh; Mainga Hamaluba; Sharon Westcar; Peter C L Beverley; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2007-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.